Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Miller Richard A Md
Relationship:   Director
City:   Sunnyvale
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   893,366    

Indirect Shares

   1,214,771      
Direct Value   $1,326,047    

Indirect Value

   $2,685,113      
Total Shares   2,108,137      
Total Value   $4,011,160      


Pharmacyclics Inc $0 Corvus Pharmaceuticals, Inc. $1,305,453 Bolt Biotherapeutics, Inc. $20,595 Pharmacyclics Inc $0 Corvus Pharmaceuticals, Inc. $1,305,453 Bolt Biotherapeutics, Inc. $20,595
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    15   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    9   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   41.2%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmacyclics Inc PCYC Pres, CEO & Director, ... 2007-08-22 300,130 2007-08-22 26,668    Premium*  
            Corvus Pharmaceuticals, Inc. CRVS 2024-05-10 577,634 2024-05-10 1,188,103    Premium*  
            Bolt Biotherapeutics, Inc. BOLT Director 2021-02-04 15,602 0    Premium*  
* Premium Members only  

Records found :    48         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CRVS Corvus Pharmaceuticals, I... President and CEOOfficer   •       •      –    2016-03-22 3 IO $0.00 $0 I/I 0 718,228 -
BOLT Bolt Biotherapeutics, Inc... Director   –       •      –    2021-02-04 3 IO $0.00 $0 D/D 0 15,602 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2016-03-29 4 A $0.00 $0 I/I 328,765 1,046,993 0 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2016-10-28 5 GD $0.00 $0 I/I 100,000 977,293 0 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-11 4 GD $0.00 $0 I/I 20,000 1,098,795 0 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2024-05-10 4 GD $0.00 $0 I/I 302,016 1,188,103 0 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-12-13 4 B $0.74 $37,015 I/I 50,000 1,480,119 2.66 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-09-28 4 B $0.76 $19,070 I/I 25,000 1,394,405 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-12-14 4 B $0.78 $7,812 I/I 10,000 1,490,119 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-09-20 4 B $0.81 $16,253 I/I 20,000 1,369,405 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-06-02 4 B $0.97 $4,898 I/I 5,000 1,338,515 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-06-27 4 B $1.00 $4,985 I/I 5,000 1,349,405 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-06-06 4 B $1.01 $899 I/I 890 1,339,405 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-06-24 4 B $1.03 $5,150 I/I 5,000 1,344,405 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-03-15 4 B $1.47 $36,650 I/I 25,000 1,313,515 2.66 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-03-17 4 B $1.59 $7,950 I/I 5,000 1,318,515 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-03-31 4 B $1.64 $24,534 I/I 15,000 1,333,515 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2024-05-06 4 B $1.73 $1,000,000 D/D 577,634 577,634 0.01 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2021-08-20 4 B $1.93 $19,254 I/I 10,000 1,288,515 2.58 %
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2007-08-21 4 B $2.00 $10,008 D/D 5,000 295,130 2.81 -
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2007-08-22 4 B $2.00 $10,000 D/D 5,000 300,130 2.81 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2021-05-04 4 B $2.80 $99,999 D/D 35,714 35,714 2.81 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2019-11-12 4 B $2.90 $789 I/I 272 1,163,779 2.58 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2019-11-13 4 B $3.00 $44,240 I/I 14,736 1,178,515 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-27 4 B $3.29 $65,884 I/I 20,000 1,128,795 2.66 -
  48  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us